NPPB and systemic sclerosis: Moreover, in the DETECT study (Detection of Pulmonary Hypertension in Systemic Sclerosis), NT-proBNP was used to stratify the risk of PAH in patients with systemic sclerosis [16], and it was also found to be correlated with hemodynamic parameters.